- University of Missouri, Columbia, MO - MD
- University of Wisconsin Hospital and Clinics - Residency in Internal Medicine
- University of Wisconsin Hospital and Clinics - Chief Resident
- University of Wisconsin Hospital and Clinics - Clinical Research Fellowship in Infectious Disease
- UW School of Medicine and Public Health - Postdoctoral Research Training, Antimicrobial Pharmacodynamics
- UW School of Medicine and Public Health - Postdoctoral Research Training, Molecular Mycology
Dr. David Andes is a faculty member and chief of the Division of Infectious Disease within the Department of Medicine, and also has an appointment in the Department of Medical Microbiology and Immunology. He holds the William A. Craig Endowed Professorship, and directs the Wisconsin Antimicrobial Drug Discovery and Development NIH Center of Excellence. Dr. Andes served as President of the International Society of Antimicrobial Pharmacology from 2008 to 2010. He is a Fellow of the Infectious Disease Society of America and the American Academy of Microbiology. He was elected as a member of the American Society of Clinical Investigation and the Association of American Physicians. Dr. Andes has received both the Puestow Award for Young Investigator in Basic Science Research and the Rankin Senior Research Award from the University of Wisconsin Department of Medicine, and has been selected for the Best Doctors in America® list every year since 2009. He is a member of the NIH Antimicrobial Resistance Leadership Group and serves at editor of Antimicrobial Agents and Chemotherapy and on the editorial boards of the Journal of Infectious Diseases, Infection and Immunity, PLOS ONE, Medical Mycology, Diagnostic Microbiology and Infectious Diseases, and Pharmaceutics. Dr. Andes is board-certified in internal medicine and infectious disease, and provides care to adult patients with a wide variety of infectious diseases in both inpatient and ambulatory settings.
Dr. Andes’ clinical interests include fungal infections, transplant infectious diseases, antimicrobial pharmacokinetics and pharmacodynamics, and travel medicine.
View Dr. David Andes’ Publications on Google Scholar.
Dr. Andes’ research program broadly focuses on understanding antibacterial and antifungal activity and drug resistance, and identifying new antimicrobial drug treatment strategies and drug targets. Study approaches include defining the molecular basis for antimicrobial drug resistance, antimicrobial drug target development, pharmacodynamic investigation, and clinical trial study of fungal diagnosis, resistance epidemiology, and therapy. Dr. Andes' research efforts have been continuously funded by the NIH since 2001. The results of these studies have been translated into clinical management guidelines, and his scientific approaches are being utilized to identify and develop the next generation of antimicrobial drugs.